A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
35
Participants
Timeline
Start Date
July 31, 2004
Primary Completion Date
September 30, 2009
Study Completion Date
April 30, 2010
Conditions
Leukemia
Interventions
DRUG
Imatinib (Gleevec)
Trial Locations (1)
M5G 2M9
Princess Margaret Hospital, Toronto
All Listed Sponsors
lead
University Health Network, Toronto
OTHER
NCT01126814 - A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter